StonvexLoading…
StonvexStonvexStonvexCore line items from CVI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $7.16B | $7.61B | $9.25B | $10.90B |
Operating Income | $182.00M | $58.00M | $1.12B | $963.00M |
Net Income | $27.00M | $7.00M | $769.00M | $463.00M |
EPS (Diluted) | $0.27 | $0.06 | $7.65 | $4.60 |
Total Assets | $3.71B | $4.26B | $4.71B | $4.12B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $511.00M | $987.00M | $581.00M | $510.00M |
Free Cash Flow OCF − CapEx | $-41.00M | $225.00M | $743.00M | $776.00M |
Shares Outstanding | 100.50M | 100.50M | 100.50M | 100.50M |